141 related articles for article (PubMed ID: 15054876)
21. Truncated bFGF-mediated cationic liposomal paclitaxel for tumor-targeted drug delivery: improved pharmacokinetics and biodistribution in tumor-bearing mice.
Wang X; Deng L; Chen X; Pei H; Cai L; Zhao X; Wei Y; Chen L
J Pharm Sci; 2011 Mar; 100(3):1196-205. PubMed ID: 20860011
[TBL] [Abstract][Full Text] [Related]
22. In vivo administration of liposomal vincristine sensitizes drug-resistant human solid tumors.
Leonetti C; Scarsella M; Semple SC; Molinari A; D'Angelo C; Stoppacciaro A; Biroccio A; Zupi G
Int J Cancer; 2004 Jul; 110(5):767-74. PubMed ID: 15146568
[TBL] [Abstract][Full Text] [Related]
23. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
[TBL] [Abstract][Full Text] [Related]
24. Anti-angiogenic effects of liposomal prednisolone phosphate on B16 melanoma in mice.
Banciu M; Schiffelers RM; Fens MH; Metselaar JM; Storm G
J Control Release; 2006 Jun; 113(1):1-8. PubMed ID: 16707187
[TBL] [Abstract][Full Text] [Related]
25. Deeper penetration into tumor tissues and enhanced in vivo antitumor activity of liposomal paclitaxel by pretreatment with angiogenesis inhibitor SU5416.
Yoshizawa Y; Ogawara K; Fushimi A; Abe S; Ishikawa K; Araki T; Molema G; Kimura T; Higaki K
Mol Pharm; 2012 Dec; 9(12):3486-94. PubMed ID: 23134499
[TBL] [Abstract][Full Text] [Related]
26. Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.
Pastorino F; Brignole C; Marimpietri D; Cilli M; Gambini C; Ribatti D; Longhi R; Allen TM; Corti A; Ponzoni M
Cancer Res; 2003 Nov; 63(21):7400-9. PubMed ID: 14612539
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer.
Landen CN; Lu C; Han LY; Coffman KT; Bruckheimer E; Halder J; Mangala LS; Merritt WM; Lin YG; Gao C; Schmandt R; Kamat AA; Li Y; Thaker P; Gershenson DM; Parikh NU; Gallick GE; Kinch MS; Sood AK
J Natl Cancer Inst; 2006 Nov; 98(21):1558-70. PubMed ID: 17077358
[TBL] [Abstract][Full Text] [Related]
28. Novel Taxol formulations: Taxol-containing liposomes.
Straubinger RM; Sharma A; Murray M; Mayhew E
J Natl Cancer Inst Monogr; 1993; (15):69-78. PubMed ID: 7912532
[TBL] [Abstract][Full Text] [Related]
29. [Microcirculatory effects of photodynamic therapy with hematoporphyrin derivative].
Feyh J; Goetz A; Heimann A; Königsberger R; Kastenbauer E
Laryngorhinootologie; 1991 Feb; 70(2):99-101. PubMed ID: 2029312
[TBL] [Abstract][Full Text] [Related]
30. The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model.
Debergh I; Van Damme N; Pattyn P; Peeters M; Ceelen WP
Br J Cancer; 2010 Mar; 102(5):837-43. PubMed ID: 20125158
[TBL] [Abstract][Full Text] [Related]
31. Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases.
Latimer P; Menchaca M; Snyder RM; Yu W; Gilbert BE; Sanders BG; Kline K
Exp Biol Med (Maywood); 2009 Oct; 234(10):1244-52. PubMed ID: 19657067
[TBL] [Abstract][Full Text] [Related]
32. Photodynamic therapy with 5-aminolevulinic acid induces distinct microcirculatory effects following systemic or topical application.
Schacht V; Szeimies RM; Abels C
Photochem Photobiol Sci; 2006 May; 5(5):452-8. PubMed ID: 16685321
[TBL] [Abstract][Full Text] [Related]
33. Liposomal encapsulation enhances the antitumour efficacy of the vascular disrupting agent ZD6126 in murine B16.F10 melanoma.
Fens MH; Hill KJ; Issa J; Ashton SE; Westwood FR; Blakey DC; Storm G; Ryan AJ; Schiffelers RM
Br J Cancer; 2008 Oct; 99(8):1256-64. PubMed ID: 18797467
[TBL] [Abstract][Full Text] [Related]
34. Thermosensitive liposomal taxol formulation: heat-mediated targeted drug delivery in murine melanoma.
Sharma D; Chelvi TP; Kaur J; Ralhan R
Melanoma Res; 1998 Jun; 8(3):240-4. PubMed ID: 9664145
[TBL] [Abstract][Full Text] [Related]
35. Contrast enhanced MRI and intravital fluorescence microscopy indicate improved tumor microcirculation in highly vascularized melanomas upon short-term anti-VEGFR treatment.
Eichhorn ME; Strieth S; Luedemann S; Kleespies A; Nöth U; Passon A; Brix G; Jauch KW; Bruns CJ; Dellian M
Cancer Biol Ther; 2008 Jul; 7(7):1006-13. PubMed ID: 18398295
[TBL] [Abstract][Full Text] [Related]
36. [Cationic liposomes loaded with doxorubicin targeting to the tumor neovasculature in vitro].
Zhao W; Ma HL; Qi XR
Yao Xue Xue Bao; 2007 Sep; 42(9):982-8. PubMed ID: 18050743
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of the alpha-nu integrins with a cyclic RGD peptide impairs angiogenesis, growth and metastasis of solid tumours in vivo.
Buerkle MA; Pahernik SA; Sutter A; Jonczyk A; Messmer K; Dellian M
Br J Cancer; 2002 Mar; 86(5):788-95. PubMed ID: 11875744
[TBL] [Abstract][Full Text] [Related]
38. Fighting cancer: from the bench to bedside using second generation cationic liposomal therapeutics.
Campbell RB; Ying B; Kuesters GM; Hemphill R
J Pharm Sci; 2009 Feb; 98(2):411-29. PubMed ID: 18563780
[TBL] [Abstract][Full Text] [Related]
39. Hemoglobin vesicles reduce hypoxia-related inflammation in critically ischemic hamster flap tissue.
Plock JA; Tromp AE; Contaldo C; Spanholtz T; Sinovcic D; Sakai H; Tsuchida E; Leunig M; Banic A; Erni D
Crit Care Med; 2007 Mar; 35(3):899-905. PubMed ID: 17255851
[TBL] [Abstract][Full Text] [Related]
40. Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizer.
Takeuchi Y; Kurohane K; Ichikawa K; Yonezawa S; Nango M; Oku N
Cancer; 2003 Apr; 97(8):2027-34. PubMed ID: 12673734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
